These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Secondary hyperlipidemia in liver diseases]. Baruch Y, Aviram M, Brook G. Harefuah; 1983 Jan 16; 104(2):61-4. PubMed ID: 6873761 [No Abstract] [Full Text] [Related]
3. Hyperlipidemia as the first biochemical manifestation of primary hepatic amyloidosis. Couture P, LeBlanc F, Gagnon P, Gagnon O, Gagné C. Am J Gastroenterol; 1997 Jun 16; 92(6):1046-7. PubMed ID: 9177530 [No Abstract] [Full Text] [Related]
13. Metabolic effects produced by alcohol in the liver and other tissues. Lieber CS. Adv Intern Med; 1968 Jan 20; 14():151-99. PubMed ID: 4387798 [No Abstract] [Full Text] [Related]
14. Acquired hyperlipidemia (secondary dyslipoproteinemias). Chait A, Brunzell JD. Endocrinol Metab Clin North Am; 1990 Jun 20; 19(2):259-78. PubMed ID: 2192873 [Abstract] [Full Text] [Related]
15. Clinical significance of abnormal lipoprotein patterns in liver diseases. Ooi K, Shiraki K, Sakurai Y, Morishita Y, Nobori T. Int J Mol Med; 2005 Apr 20; 15(4):655-60. PubMed ID: 15754028 [Abstract] [Full Text] [Related]
16. Role of the liver in hyperlipidemia. Havel RJ. Semin Liver Dis; 1992 Nov 20; 12(4):356-63. PubMed ID: 1465620 [No Abstract] [Full Text] [Related]